Biological object
Protein, DNA, RNA, molecule, cell, tissue, image and spatial neighborhood are different scientific objects. BioAtlas keeps the modality and scale explicit.
BioAtlas separates the biological object from its computational representation: sequence tokens, structural alphabets, molecular graphs, all-atom coordinates, gene-expression vectors, spatial graphs, tissue images and other forms are tracked explicitly alongside architecture, objective, output and validation.
Protein, DNA, RNA, molecule, cell, tissue, image and spatial neighborhood are different scientific objects. BioAtlas keeps the modality and scale explicit.
Track how the object becomes computation: sequence tokens, graphs, pair features, 3D coordinates, expression vectors, embeddings, image patches or spatial graphs.
Separate Transformer, diffusion, GNN, state-space, physics and hybrid architectures from the objective used to learn or generate the representation.
Predictions, embeddings, structures and generated candidates are linked to task-specific evidence rather than being collapsed into a universal model score.
Compare AI models for protein and biomolecular structure prediction using source-linked capabilities, access, benchmarks, versions and known limitations.
Explore evidence →Explore AI docking and protein–ligand pose models with benchmark context, access terms, input/output contracts and evidence boundaries.
Explore evidence →Compare generative protein and binder-design models, including evidence, access, experimental validation, workflows and limitations.
Explore evidence →Explore AI foundation models for DNA, RNA and genomic sequence understanding with evidence, versions, access and scientific limitations.
Explore evidence →Compare virtual-cell, single-cell and perturbation-prediction models by inputs, outputs, benchmark context and evidence limitations.
Explore evidence →Structure accuracy, docking pose accuracy, affinity ranking, representation transfer, generation quality and perturbation prediction are different metrics and should not be collapsed into one readiness score.
A model family can change architecture, scope, representation, access terms and benchmark behavior between releases. Unknown version histories remain pending rather than receiving inferred dates.
A model, a checkpoint, a platform and a company are different entities. BioAtlas now labels them explicitly instead of presenting every item as the same kind of model.
Developer-reported, preprint, peer-reviewed, independently reproduced and experimentally validated evidence can be tracked separately, with source links and caveats retained.